Abrdn Healthcare Investors (HQH) Stock

About Abrdn Healthcare Investors

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Abrdn Healthcare Investors is headquartered in US.

Abrdn Healthcare Investors (HQH) stock trades at $21.59 with a market capitalization of $1.23B. The stock is valued at a price-to-earnings (P/E) ratio of 11.73, price-to-book of 1.06, price-to-sales of 12.37. Over the past 52 weeks the stock has ranged between $15.51 and $22.29, and currently trades 3.1% below its 52-week high. It pays a dividend yielding 11.30%.

On profitability, Abrdn Healthcare Investors generates a return on equity (ROE) of 9.16%, return on capital employed of 9.00%, an operating margin of 98.80%, a net profit margin of 98.80%.

Official website: www.teklacap.com